Pancreatic Reference Set Application: Kazufumi Honda-National Cancer Center (2014)

Abbreviated Name
Pancreatic Ref Set App: Honda (2014)
Lead Investigator
Honda, KazufumiNippon Medical School
Coordinating Investigator
Feng, Ziding Fred Hutchinson Cancer Center
Involved Investigators

Abstact

See objectives

Aims

To improve the survival rate of pancreatic cancer, non-invasive diagnostic methods that detect the disease in its early stage must be developed.

Analytic Method

The National Cancer Institute (NCI) will send the pancreatic cancer reference serum samples to the National Cancer Center, and the National Cancer Center (NCC) will then blindly measure the levels of apoAII isoforms in the reference samples. NCC will return the data obtained from the reference set, and the NCI will subsequently calculate sensitivity, specificity, and the AUC. In addition, the NCI will evaluate the clinical utility for early detection of pancreatic cancer

Biomarkers

Data Collections

  • No data available at this time for this protocol
Protocol ID
392
Protocol Type
Reference Set
Field of Research
Proteomics
Collaborative Group
G.I. and Other Associated Cancers Research Group
Cancer Types
  • Malignant neoplasm of pancreas
Phased Status
1

Associated Forms